Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-24-002769
Filing Date
2024-04-05
Accepted
2024-04-05 16:05:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 ARCA BIOPHARMA, INC. p24-1381sc13d.htm SC 13D 81074
2 JOINT FILING AGREEMENT p24-1381exhibit99.htm EX-99 3219
  Complete submission text file 0000902664-24-002769.txt   86063
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51477 | Film No.: 24826460
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D